78 related articles for article (PubMed ID: 1187001)
1. [Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment].
Campanacci L; Huber W; Bertoli M; Cancarini GC; Toigo G
Minerva Med; 1975 Oct; 66(68):3547-65. PubMed ID: 1187001
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of ampicillin and of pivampicillin in normal subjects and in chronic uremic patients treated with periodical hemodialysis].
Bertoli M; Huber W; Cancarini GC; Toigo G; Romagnoli GF
G Clin Med; 1976; 57(3-4):105-12. PubMed ID: 1001853
[No Abstract] [Full Text] [Related]
4. [Antibiotics in renal insufficiency (author's transl)].
Möhring K; Schüler HW; Stöhrer M
Prakt Anaesth; 1974 Feb; 9(1):16-23. PubMed ID: 4376238
[No Abstract] [Full Text] [Related]
5. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
6. The effects of a Lundh meal on the plasma concentration/time curve of ampicillin, amoxycillin, pivampicillin and cephalexin in normal subjects [proceedings].
Parsons RL; Hossack GA; Paddock GM; Trounce JR
Br J Clin Pharmacol; 1977 Jun; 4(3):406P-407P. PubMed ID: 901729
[No Abstract] [Full Text] [Related]
7. [The effect of pivampicillin and probenecid on experimental syphilis in rabbits].
Petzoldt D
Hautarzt; 1975 Aug; 26(8):423-4. PubMed ID: 1182027
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute pelvic infections with alphacillin (pivampicillin Hcl).
Grech ES; Mutale EM; Bathirunatham N
Med J Zambia; 1977; 11(4):99-103. PubMed ID: 919787
[TBL] [Abstract][Full Text] [Related]
9. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of ampicillin in patients with kidney allograft].
Iarmolinskii IS; Vasina TA; Goriainov VA
Antibiotiki; 1971 Jul; 16(7):661-3. PubMed ID: 4945581
[No Abstract] [Full Text] [Related]
11. [Cephaloridine. Adjustment of its dosage to the degree of renal insufficiency and administration during chronic uremia treated by repeated hemodialysis].
Brogard JM; Ruscher H; Frankhauser J; Jahn H; Dammron A
Ann Med Interne (Paris); 1970 Dec; 121(12):1027-38. PubMed ID: 5504233
[No Abstract] [Full Text] [Related]
12. [Administration of cephalothin and cephloridine in uremic patients with hemodialysis].
Takayasu H; Kitagawa R; Miyamura R; Koiso K; Kano S
Saishin Igaku; 1971 Jun; 26(6):1173-7. PubMed ID: 5098182
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of norfloxacin in chronic renal failure.
Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin secretion in chronic renal patients treated with hemodialysis.
Gozariu L; Manasia M; Paţiu IM; Vlăduţiu D; Barabas E; Spânu C; Căprioară M
Endocrinologie; 1981; 19(4):253-6. PubMed ID: 7323650
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of anakinra in subjects with different levels of renal function.
Yang BB; Baughman S; Sullivan JT
Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
[TBL] [Abstract][Full Text] [Related]
17. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
18. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ofloxacin in severe chronic renal failure.
Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
Clin Ther; 1989; 11(2):210-8. PubMed ID: 2736567
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia in children on renal replacement therapy.
Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
